The tweet was deleted by the author.
But we saved everything 🙂.
The adoption of artificial intelligence is accelerating in the medical diagnostics sector. Eric Lefkofsky announced the Preview platform, which uses proprietary AI models trained on millions of pathology slides to provide doctors with critical insights within 24 hours of sample receipt. According to Lefkofsky, this product is set to transform patient care by making timely analysis more accessible to clinicians. The technology has the potential to reshape the diagnostic workflow, enabling faster and possibly more accurate treatment decisions.
Lefkofsky’s latest announcement follows recent regulatory milestones for his healthcare ventures. Earlier this year, Tempus secured U.S. FDA approval for its tumor-only xT CDx genomic profiling test. The green light expanded advanced diagnostics options for more patients.